Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX.DL)

CAPS Rating: No stars

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

1
Player Avatar CarlosDK (21.06) Submitted: 1/21/2013 8:00:23 PM : Underperform Start Price: $76.77 ONXX.DL Score: -49.17

High value in all fin stockscreener

Featured Broker Partners


Advertisement